Therapeutic Advances in Drug Safety
Journal Highlights
- Launched in 2010.
- Gold open access journal – all articles are made freely available online immediately upon publication.
- Rigorous peer review.
- Listed in PubMed and indexed in Clarivate Analytics: Science Citation Index Expanded (SCIE), Scopus, and International Pharmaceutical Abstracts (ProQuest).
- Over 220,000 full article views annually.
Therapeutic Advances in Drug Safety is a peer-reviewed open access journal which focuses on pioneering efforts and innovative studies across all areas of drug safety. Please see the Aims and Scope tab for further information.
The journal is a member of the Committee on Publication Ethics (COPE).
Diversity, Equity and Inclusion Statement
Therapeutic Advances in Drug Safety (TADS) promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the drug safety community.
Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.
We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.
We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.
Submission information
Submit your manuscript today at http://mc.manuscriptcentral.com/tads.
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Open access information
The article processing charge (APC) for this journal is currently USD 2800. The APC for a Plain Language Summary is $4500.
The APC is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.
Contact
Please direct any enquiries to tads@sagepub.co.uk.
This journal changed its publication mode from subscription to open access in 2019.
Therapeutic Advances in Drug Safety delivers the highest quality peer-reviewed open access original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in drug safety, providing an online forum for rapid dissemination of recent research and perspectives in this area.
The journal is dedicated to publishing clinical research, including qualitative studies. We do not publish preclinical research, including basic laboratory research and animal studies.
Review articles include expert opinion pieces, perspective reviews (including single-drug and drug class reviews), patient perspectives, narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
The journal adheres to a blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees.
| Arduino Mangoni MD, MRCP (UK), FRACP, FRCP (London), FRCP (Glasgow), FRCP (Edinburgh) | Flinders Medical Centre and Flinders University, Bedford Park, Australia |
| Shasha Sharief | SAGE Publishing, London, UK |
| Pramila Gawali | SAGE Publishing, India |
| Nisha Kaushik | SAGE Publishing, India |
| Joris Berwaerts MD | J&J Pharmaceutical Research & Development, USA |
| Matthew P. Doogue BSc, MBCHB, DipPaed, FRACP | Univeristy of Otago Christchurch, New Zealand |
| Debabrata Roy, PhD | Drug Safety Research Unit, Southampton, UK |
| Roy Soiza MB, ChB. MRCP | NHS Grampian, Aberdeen, UK |
| Stephen Waring BMedSci, MB, BCh, BAO, PhD | York Hospitals NHS Trust, UK |
| Royes Joseph, PhD | School of Medicine, Keele University, UK |
| Chang-Xing Ma, PhD | Department of Biostatistics, University at Buffalo, New York, USA |
| Mandy Michelle McBroom MPH | UT Southwestern Medical Center, USA |
| Yoshihiro Noguchi, PhD | Gifu Pharmaceutical University, Japan |
| Shikha Sapkota | SAGE Publishing, India |
| Sara Tommasi, PhD | Flinders University, Adelaide, Australia |
| Anna Birna Almarsdóttir PdD, MS, MSc | University of Copenhagen, Copenhagen, Denmark |
| Christopher Beer MB, BS, GradCertHPEd, PhD, FRACP | Royal Perth Hospital, Perth, WA, Australia |
| J Simon Bell PhD | Monash University, Melbourne, Australia |
| Phil Berry MBBS, Mphil | Independent Pharmaceutical Consultant, Geneva, Switzerland |
| Carlos-Alberto Calderon-Ospina MD, PhD, MSc | Pharmacology Unit, School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia |
| Kin-Wei Chan MD, ScD, FISPE | National Taiwan University, Taipei, Taiwan |
| Antonio Cherubini MD, PhD | IRCCS INRCA, Ancona, Italy |
| Bernard Cheung MA, MB BChir, PhD, MRCP, FRCP, FCP, FHKCP, FHKAM (Medicine) | The University of Hong Kong, Hong Kong |
| Claire Davies | Medicines and Healthcare Products Regulatory Agency, London, UK |
| Alex Dodoo B.Pharm, MSc, PhD, FPSGH, FPCPharm | University of Ghana Medical School, Accra, Ghana |
| Phil Hannaford MBChB | University of Aberdeen, Aberdeen, UK |
| Manfred Hauben MD, PhD | New York, NY, USA |
| Sarah Hilmer BScMed, MBBS, FRACP, PhD | Royal North Shore Hospital, St Leonards, NSW, Australia |
| Paul Jansen MD, PhD | University Medical Centre, Utrecht, Netherlands |
| Jimmy Jose MPharm, PhD | School of Pharmacy, University of Nizwa, Oman |
| Neil Kaplowitz MD | University of Southern California, Los Angeles, CA, USA |
| Star Khoza, PhD | University of the Western Cape, South Africa |
| Stephen Leslie BSc, MB ChB, PhD, FRCP | Raigmore Hospital, Inverness, UK |
| Sunny Linnebur Pharm.D, FCCO, BCPS, CGP | Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Denver, Colorado, USA |
| Mary J Macleod BSc, MBChB, PhD, FRCP | University of Aberdeen, Aberdeen, UK |
| Jennifer Martin MA, MBBS, PhD | University of Queensland, Brisbane, QLD, Australia |
| Glenn Matfin MB, ChB | National Health Service, London, UK |
| Patricia Mcgettigan MD, FRCPI, FRACP | Hull York Medical School, Hull/York, UK |
| Christoph Meier PhD, MSc | University Hospital Basel, Basel, Switzerland |
| Tadele Mekuriya Yadesa, B.Pharm, MSc, Ph.D | Kampala International University, Uganda |
| Yola Moride PhD, FISPE | Rutgers University, New Jersey, USA |
| Vicky Parikh MD, PPH | Mid-Atlantic Medical Research Centers, Hollywood, MD, USA |
| Emilio Perucca | University of Pavia, Pavia, Italy |
| Philip Pierce MD | Johnson & Johnson Pharmaceutical Research and Development, Titusville, NJ, USA |
| Munir Pirmohamed BChB, MRCO, PhD, FRCP, FBPharmacolS | University of Liverpool, Liverpool, UK |
| Thomas M. Polasek BSc, BPharm, PhD | Flinders University, Adelaide, SA, Australia |
| Elena Ramírez, PhD, MD | Autonomous University of Madrid, Spain |
| Amrit Ray MD, MBA | Johnson & Johnson Pharmaceuticals Group, Titusville, NJ, USA |
| Michael Rieder MD, PhD | Childrens Hospital of W. Ontario, London, ON, Canada |
| Luis Rios-Nogales MD, PhD | Rational Vaccines, Boston, MA, USA |
| Greg Roberts Bpharm | Repatriation General Hospital, Daw Park, SA, Australia |
| Allen Root | University of South Florida, USA |
| Andrew Rowland | Flinders University, Australia |
| Leo Russo MS, PhD | Shire Pharmaceuticals, Wayne, PA, USA |
| Mohammed Salahudeen BPharm, PharmD, MBA, PhD, AFHEA | School of Pharmacy and Pharmacology, University of Tasmania, Hobart, Australia |
| Marco Sardella, PharmD, EEA QPPV | ADIENNE Pharma & Biotech, Monza e Brianza, Italy |
| Carmelo Scarpignato MD, DSc, FRCP, FACP, FACG | University of Parma, Parma, Italy |
| Rashmi Shah BSc, MBBS, FRCP, FRCP, MD, FFPM, HonFBPhS | Rashmi Shah Consultancy Ltd, Gerrards Cross, UK |
| Michael Sorich | Flinders University, Australia |
| Scott Twaddell BMedSc, BMed, GCClinTox, FRACP | University of Newcastle, Newcastle, NSW, Australia |
| Allen Vaida PharmD, BSc | Institute of Safe Medication Practices, Horsham, PA, USA |
| Tjeerd Van Staa MD, PhD, MA, MSc | Medicines and Healthcare Products Regulatory Agency, London, UK |
| David Williams PhD, FRCP | Royal College of Surgeons, Eire, Ireland |
| Richard Woodman PhD, MBiostats, MMedSco, BSc | Flinders Centre for Epidemiology and Biostatistics, Flinders University, Adelaide, Australia |
| Jane Woolley PhD | Medicines and Healthcare products Regulatory Agency, USA |
| Jian Zhang, PhD | Zhujiang Hospital of Southern Medical University, China |
| Tina Aswani Omprakash | Patient Advocate |
| Trishna Bharadia | Patient Advocate, Maidenhead, UK |
| Anisha Gangotra | Patient Advocate, High Wycombe, UK |
| Dominique Hamerlijnck MPhil, MBA | European Patients' Academy (EUPATI), Amsterdam, Netherlands |
| Sheila Khawaja | The World Alliance of Pituitary Organizations (WAPO), Monfalcone, Italy |
| Paola Kruger | European Patients' Academy (EUPATI), Rome, Italy |
| Oisín Kavanagh, MPharm, MPSI, MPSNI, PhD | Newcastle University, United Kingdom |
| Olivia Lounsbury, BS | Johns Hopkins Hospital, Baltimore, MD, USA |
| Sule Ajibola Saka, BPharm; MPharm; PhD, UKZN | Faculty of Pharmacy, Olabisi Onabanjo University, Agoiwoye, Nigeria |
| Vasileios-Periklis Stamatellos, MD, MSc | Aristotle University of Thessaloniki, Department of Clinical Pharmacology, Greece |
| Tesfay Mehari Atey, PhD, MBA, MSc, BPharm | Department of Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Mekelle University School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania |
| Jaden Brandt, BSc.Pharm, MSc, DipPH | University of Manitoba, Manitoba, Canada |
| Jaqueline Eserian, PhD | Adolfo Lutz Institute, São Paulo, Brazil |
| Jennifer Ilomaki, Msc, MD | Centre for Medicine Use and Safety, Monash University, Australia |
| Noami Jessurun, PharmD, PhD | Pharmacovigilance Centre Lareb, The Netherlands |
| Mahmathi Karuppannan, BPharm (Hons.), MPharm, Ph.D | Universiti Teknologi MARA, Shah Alam Selangor, Malaysia |
| Ronald Kiguba, BPharm, MSc, PhD | Makerere University College of Health Sciences, Uganda |
| Syed Arman Rabbani, PhD | RAK Medical & Health Sciences University, UAE |
| Daniela A. Rodrigues, MSc | Research Laboratory on Epidemiology and Population Health, Polytechnic of Guarda, Portugal |
| Maha Saad, PharmD, BCGP, BCPS | St. John's University College of Pharmacy and Health Sciences, UK |
| Carrie Stewart, PhD | Institute of Applied Health Sciences, University of Aberdeen, Scotland |
| Selvarani Subbarayan, MBBS, MSc., PhD | Novabiotics, UK |
| Mojtaba Vaismoradi, Prof., PhD, MScN, BScN | Nord University, Bodø, Norway |
| Chen-Yu Wang, PhD | National Center for Geriatric and Welfare Research, National Health Research Institutes, Miaoli County, Taiwan |
| Nadir Yalcin, PhD | Hacettepe University, Ankara, Turkey |
- Clarivate Analytics: Current Contents - Clinical Medicine
- Clarivate Analytics: Science Citation Index Expanded (SCIE)
- Directory of Open Access Journals (DOAJ)
- ProQuest
- PubMed Central (PMC)
- Scopus
Manuscript submission guidelines can be accessed on Sage Journals.